Clinical Trials Logo

Clinical Trial Summary

Cannabis is one of the widely used psychoactive substances in the world. With increasing legalization, the prevalence of driving under the influence of cannabis will undoubtedly rise. At present, roadside detection of cannabis intoxication is largely dependent on drug recognition experts who rely on changes in eye movements when impaired. In this regard, use of eye trackers can help to detect impairment in drivers. The purpose of the present study is to determine the feasibility of the use of eye trackers in detecting impairment in participants who smoked a cannabis cigarette.


Clinical Trial Description

Participants will attend one study session after determination of eligibility. During this session, they will smoke a cannabis cigarette with 12.5% THC prior to driving a simulator. Driving will be assessed prior to smoking cannabis and at 7 time points after smoking cannabis. Eye tracking measures will also be taken while driving after smoking cannabis. Blood will be drawn for determination of levels of the psychoactive substance THC and its metabolites. Saliva tests, urine tests and subjective tests will also be performed at various times points after smoking cannabis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03813602
Study type Interventional
Source Centre for Addiction and Mental Health
Contact
Status Completed
Phase Phase 1/Phase 2
Start date August 15, 2019
Completion date November 15, 2019

See also
  Status Clinical Trial Phase
Completed NCT04851392 - Do Adolescents and Adults Differ in Their Acute Response to Cannabis? N/A
Terminated NCT03994926 - Evaluation of an Eye Tracking Sensor to Detect Cannabis Impairment Early Phase 1
Completed NCT02849587 - The Impact and Detection of Driving Impairments Associated With Acute Cannabis Smoking Phase 1/Phase 2
Recruiting NCT04931095 - The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment Phase 1
Completed NCT04799093 - Eye Movement Tracking to Detect Impairment Due to Acute Cannabis Intoxication
Not yet recruiting NCT06293040 - Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment Phase 1
Withdrawn NCT05273658 - Effects of Cannabis/Alcohol on Driving Performance and Field Sobriety Tests Phase 1/Phase 2
Not yet recruiting NCT04855526 - THC + CBD and Memory Study Early Phase 1